The economic newpaper Expansión reports on the 20th anniversary of the Barcelona Science Park (Parque Científico de Barcelona (PCB). In the article, it mentions that, in addition to hosting biomedical start-ups like Oryzon Genomics, PaloBiofarma, Som Biotech and Kymos Pharma, it is also home to prestigious organisations such as the Institute for Research in Biomedicine (IRB Barcelona), the Instituto de Biología Molecular de Barcelona (IBMB-CSIC), and large companies linked to innovation, such as Esteve and Grupo Ordesa.
"This combination of organisations on the same site makes the PCB unique," explains the director of the PCB, Maria Terrades. "...
It is estimated that around 400,000 people in Catalonia have a rare disease. In Spain this figure reaches 3 million and in Europe 30 million. In spite of the number of people affected, rare diseases have little visibility. Although promising breakthroughs have been made, these diseases are usually chronic, weakening, and multisystem disorders.
The programme “El Balcó” broadcasted by the radio station Cadena Ser devoted its section called "L'estat de las coses" to rare diseases. They invited Francesc Palau, paediatrician at Sant Joan de Déu Hospital, Isabel Gemio, president of the Fundación Isabel Gemio, and Joan J. Guinovart,...
The newspaper “La Opinión de Zamora” has published an article devoted to breast cancer, one of the tumours most widely diagnosed in women in Spain and one of the most lethal.
The newspaper is organising a conference on breast cancer on 18 October, to which Angel R. Nebreda, ICREA researcher at IRBBarcelona, has been invited. The scientist will explain the breakthroughs achieved in basic research that can contribute to personalised treatments. Recently, Nebreda’s lab published a paper in the journal Cancer Cell reporting on a mechanism that prevents tumour cells...
El Punt Avui and La Vanguardia have published an article about the European Research Council (ERC) Proof of Concept grants. Five of them were given to centres belonging to the Barcelona Institute of Science and Technology (BIST), two corresponding to researchers Eduard Batlle and Angel R. Nebreda at IRB Barcelona.
Link to La Vanguardia: España, líder en la última convocatoria de ciencia europea (in Spanish)
Link to El Punt Avui:...
El País newspaper has published an article about the communication campaign of "Legado Solidario", an initiative launched on the International Legacy Day that brings together 25 non-profit organisations, amongst them the IRB Barcelona, and that aims to inform and encourage citizens to make a donation in a will to a charitable cause.
Link to El País: Cómo donar parte de tu herencia a una ONG (in Spanish)
Link to the IRB Barceloan news: a la noticia del IRB Barcelona:...
The magazine Cambio 16 has wrote an article on the 20 projects that the "la Caixa" Foundation has awarded to promote excellence in the fight against diseases that have a big impact in the world. One of these projects is the "Metastasis Cell Fate Mapping" by Roger Gomis, ICREA researcher at IRB Barcelona, who will develop strategies to compensate for the effect of mutations that influence the progression of breast cancer in order to find new treatments.
El Mundo Innovadores has done a report on the project "Escoles Tàndem", an initiative of pedagogical innovation promoted by Catalunya La Pedrera Foundation and in which IRB Barcelona has participated. This project unites schools and institutes with specialized institutions for three years to renew educational strategies.
El Independiente, Catalunya Ràdio and La Vanguardia have interviewed Raúl Méndez, ICREA researcher at IRB Barcelona, to learn more about the recently published study on autism. Méndez points out that despite the importance of the discovery, "we are 'far away' from achieving a cure or solution to the autism spectrum disorder, although it will allow us to focus future studies in this direction."
Link to El Independiente
Link to...
RTVE, Ara, 20 Minutos, Daily Mail, Jornal Médico, Sic Noticias, among other national and international media, have published articles about a recent study on autism. Researchers co-led by Raúl Méndez, head of the Translational Control of Cell Cycle and Differentiation Lab at IRB Barcelona, have discovered that the protein CPEB4, a molecule that regulates protein synthesis, is impaired in most cases of autism.
Link to RTVE
Link to...
Immunotherapy is gaining ground in the fight against cancer. The tumour has a strategy to evade detection by the immune system, thus allowing it to spread throughout the body. Science has discovered this therapy and is working on overcoming this evasion strategy. In this regard, La República has published an interview with Eduard Batlle, head of the Colorectal Cancer Lab at IRB Barcelona.
